Ummugul Uyeturk

Dr. Ummugul Uyeturk

Auto-generated profile, based on publicly available information

Dr. Ummugul Uyeturk


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2013 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
UUUmmugul Uyeturk
Ummugul Uyeturk
ATAli Murat Tatli
Ali Murat Tatli
SGSebahat Gucuk
Sebahat Gucuk
BOBerna Oksuzoglu
Berna Oksuzoglu
AUArife Ulas
Arife Ulas
HEHasan Ergenc
Hasan Ergenc
Breast cancer (BC) is the one of the most common cancers in women. It is also a leading cause of death. Unfortunately, some patients initially present with distant metastases and are diagnosed with stage IV disease that is nearly always, by then, incurable. This retrospective analysis investigated the risk factors for stage IV BC that may underlie such late presentation. In all, 916 patients with BC who visited the medical oncology polyclinic of eight different centres in Turkeybetween December 2011 and January 2013 were analysed. A total of 115 patients (12.6%) presented with stage IV disease. In univariate analysis; to comparing these with patients at other stages, no statistical difference was found for median diagnosis age or age at menarche (p=0.611 and p=0.820), whereas age at menopause and age at first live birth were significant (p=0.018 and p=0.003). No difference was detected in terms of accompanying diseases, use of oral contraceptives and hormone replacement therapy, smoking, alcohol consumption and the rate of family history of BC between the patients (p=0.655, p=0.389, p=0.762, p=0.813, p=0.229, p=0.737). However, screening methods were employed less often, the rate of illiteracy was higher, and the rate of other cancers was higher in patients with stage IV BC (p=0.022, p=0.022, p=0.018). No statistical difference was observed between the patients in terms of tumour histopathology, and status of oestrogen receptor, progesterone receptor, or human epidermal growth factor-2 receptor (p=0.389, p=0.326, p=0.949, p=0.326). Grade 3 tumours were more frequent in patients with stage IV disease (p<0.001). On multivariate analysis, risk factors for stage IV breast cancer at the time of presentation were found to be age at first live birth and educational level (p=0.003 and p=0.047). Efforts should be made to perform mammography scans, in particular, at regular intervals through national training programs for all women, particularly those with family histories of breast and other types of cancer, and to establish early diagnosis of BC long before it proceeds to stage IV. Additionally, women's education had better be upgraded. In order to make women aware of BC, national education-programmes must be organised.

1 January 2013 in Contemporary Oncology
Verified
Journal Article
Open access
UUUmmugul Uyeturk
Ummugul Uyeturk
SASerife Hulya Arslan
Serife Hulya Arslan
OBOznur Bal
Oznur Bal
UAUlku Yalcintas Arslan
Ulku Yalcintas Arslan
OOOmur Berna Cakmak Oksuzoglu
Omur Berna Cakmak Oksuzoglu
Introduction: Gastric cancer, one of the most common cancers in the world, rarely metastasizes to the ovaries. Ovarian metastases of gastric signet ring cell cancer (SRCC) are referred to as Krukenberg tumors and account for 1–2% of all ovarian cancers. Here, we analyze the characteristics,...

22 March 2014 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
UUUmmugul Uyeturk
Ummugul Uyeturk
BOBerna Oksuzoglu
Berna Oksuzoglu
TATulay Akman
Tulay Akman
ITIbrahim Turker
Ibrahim Turker
NSNur Sener
Nur Sener
MUMukremin Uysal
Mukremin Uysal

1 October 2011 in Turkish Journal of Hematology
Verified
Journal Article
Open access
SASerife Hulya Arslan
Serife Hulya Arslan
UUUmmugul Uyeturk
Ummugul Uyeturk
ETEmre Tekgunduz
Emre Tekgunduz
SISultan Cigdem Irkkan
Sultan Cigdem Irkkan
MYMeltem Kurt Yuksel
Meltem Kurt Yuksel
FAFevzi Altuntaş
Fevzi Altuntaş
Primary non-Hodgkin’s lymphoma (NHL) of the breast constitutes 0.04%-0.53% of all malignancies and 2.2% of extra nodal lymphomas. In total, 7%-8% of all B-cell lymphomas are the mucosa-associated lymphoid tissue (MALT) type, of which up to 50% of primary gastric MALT lymphoma. Herein we present a patient with breast MALT lymphoma that transformed to diffuse large B-cell lymphoma (DLBCL). A 69-year-old female presented with a mass on her left breast. Physical examination showed a 3 × 3-cm mass located 1 cm from the areola on the upper lateral quadrant of the breast at the 1 o’clock position, which was fixed and firm. Excisional biopsy was performed and pathologic examination of the specimen showed MALT lymphoma transformation to DLBCL. The patient was staged as II-EA. The rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) protocol was scheduled as treatment. Following 6 courses of R-CHOP, 2 additional courses of rituximab were administered. Positron emission tomography (PET)-CT was done at the end of the treatment. PET showed that the patient was in complete remission. At the time this report was written, the patient was being followed-up at the outpatient clinic on a regular basis. Lymphoma of the breast is a rarity among malignant tumors of the breast. The most common type of lymphoma is DLBCL. Breast MALT lymphoma is extremely rare. Primary MALT lymphoma of the breast can transform from low grade to high grade and recurrence is possible; therefore, such patients should be monitored carefully for transformation.u

20 November 2012 in Hepatogastroenterology
Verified
Journal Article
Closed access
MSMesut Seker
Mesut Seker
ASAlper Sevinc
Alper Sevinc
RYRamazan Yildiz
Ramazan Yildiz
SCSener Cihan
Sener Cihan
MKMuhammet Ali Kaplan
Muhammet Ali Kaplan
A(Anatolian Society Of Medical Oncology (Asmo)
Anatolian Society Of Medical Oncology (Asmo)
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasm of the gastrointestinal tract. In an attempt to survey the approximate incidence, clinicopathological characteristics, and immunophenotypic features of GISTs in Turkey, we conducted a clinicopathological and immunohistochemical analysis of GISTs. Three hundred and thirty-three patients with GIST from nine institutions in Turkey were retrospectively evaluated. Between January 2001 and March 2011, a total of 333 patients with GISTs were included; of these, 204 (61.2%) were male and 129 (38.8%) were female. The median age was 55 years (range; 22-102 years). At the median follow-up of 26 months (range; 4-166 months), the 1-, 3- and 5-year OS rates of the 333 patients were 96.9%, 85.8% and 78.5%, respectively. The 5-year DFS rate was 40%. The 5-year OS rate and median OS time for the patients with R0 resection were significantly higher than for patients with metastatic diseases (79.7 vs. 75.7% and not reached vs. 115 months, respectively, p=0.04). Although our results should be confirmed by prospective studies, we believe that they contribute to the literature because the study included both resectable and metastatic or unresectable GIST patients and multicenter findings from Turkey.

1 June 2011 in Turkish Journal of Hematology
Verified
Journal Article
Closed access
UUUmmugul Uyeturk
Ummugul Uyeturk
SASerife Hulya Arslan
Serife Hulya Arslan
MYMeltem Kurt Yuksel
Meltem Kurt Yuksel
FAFevzi Altuntas
Fevzi Altuntas